XORTX Therapeutics Annual General and Special Meeting of Shareholders.
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/21/25 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments |
|
4 | |
| 01/06/25 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments |
|
5 | |
| 12/19/24 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments |
|
4 | |
| 12/13/24 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
1 | |
| 12/12/24 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments |
|
5 | |
| 11/25/24 | EFFECT | Notice of Effectiveness |
|
1 | |
| 11/22/24 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 11/22/24 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
28 | |
| 11/22/24 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
28 | |
| 11/20/24 | UPLOAD | SEC-generated letter |
|
1 |